15:43 28.04.26
Erstelle meine Watchlist und Depot login | Registrieren
Amgen Inc US0311621009

Amgen "sell"

17.07.07 - Lazard Capital Markets

NEW YORK, July 17 (newratings.com) - In a research note published yesterday, analysts at Lazard Capital maintain their "sell" rating on Amgen Inc (AMGN). The target price is set to $50.

                                                                                                                        

Verbessern Sie newratings! Was könnte newratings besser machen?